FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1235.475

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113762.1.4.1235.475
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1235.475/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.475
Version20250208
Statusactive
Date2025-02-08T01:04:21-05:00
NameOGTT_LOINC
TitleOGTT_LOINC
Realmus
Authorityhl7
Descriptionb.well created value set by Sr. Clinical Business Analyst for OGTT - Oral glucose tolerance tests.
Purpose(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute OGTT for inclusion and utilization in patients/users connected heath.),(Data Element Scope: OGTT for b.well.),(Inclusion Criteria: OGTT Codes that constitute the Clinical Grouping Event for b.well.),(Exclusion Criteria: N/A)

Resources that use this resource

ValueSet
2.16.840.1.113762.1.4.1235.476OGTT_Grouping

Resources that this resource uses

CodeSystem
loinc.orgLOINC Code System

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1235.475",
  "meta": {
    "versionId": "7",
    "lastUpdated": "2025-02-08T01:04:21.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "B.well Connected Health Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-02-08"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2025-02-08"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.475",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1235.475"
    }
  ],
  "version": "20250208",
  "name": "OGTT_LOINC",
  "title": "OGTT_LOINC",
  "status": "active",
  "date": "2025-02-08T01:04:21-05:00",
  "publisher": "B.well Connected Health Steward",
  "description": "b.well created value set by Sr. Clinical Business Analyst for OGTT - Oral glucose tolerance tests.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute OGTT for inclusion and utilization in patients/users connected heath.),(Data Element Scope: OGTT for b.well.),(Inclusion Criteria: OGTT Codes that constitute the Clinical Grouping Event for b.well.),(Exclusion Criteria: N/A)",
  "compose": {
    "include": [
      {
        "system": "http://loinc.org",
        "concept": [
          {
            "code": "1496-9",
            "display": "Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO"
          },
          {
            "code": "1507-3",
            "display": "Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO"
          },
          {
            "code": "1518-0",
            "display": "Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO"
          },
          {
            "code": "1533-9",
            "display": "Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO"
          },
          {
            "code": "1539-6",
            "display": "Glucose [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO"
          },
          {
            "code": "21004-7",
            "display": "Glucose tolerance [Interpretation] in Serum or Plasma"
          },
          {
            "code": "49688-5",
            "display": "Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO"
          },
          {
            "code": "50667-5",
            "display": "Glucose tolerance [Interpretation] in Serum or Plasma Narrative"
          },
          {
            "code": "62856-0",
            "display": "PhenX - oral glucose tolerance test protocol 141001"
          },
          {
            "code": "6749-6",
            "display": "Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO"
          },
          {
            "code": "LA33717-2",
            "display": "Impaired glucose tolerance"
          },
          {
            "code": "LP112419-9",
            "display": "PhenX - oral glucose tolerance test protocol 141001"
          },
          {
            "code": "LP65536-2",
            "display": "Glucose tolerance 3H panel"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:f8ee6c70-a50b-4b64-84a3-ac4bb5d8dd3b",
    "timestamp": "2025-05-23T20:28:09-04:00",
    "total": 13,
    "contains": [
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "1496-9",
        "display": "Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "1507-3",
        "display": "Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "1518-0",
        "display": "Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "1533-9",
        "display": "Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "1539-6",
        "display": "Glucose [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "21004-7",
        "display": "Glucose tolerance [Interpretation] in Serum or Plasma"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "49688-5",
        "display": "Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "50667-5",
        "display": "Glucose tolerance [Interpretation] in Serum or Plasma Narrative"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "62856-0",
        "display": "PhenX - oral glucose tolerance test protocol 141001"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "6749-6",
        "display": "Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "LA33717-2",
        "display": "Impaired glucose tolerance"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "LP112419-9",
        "display": "PhenX - oral glucose tolerance test protocol 141001"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "LP65536-2",
        "display": "Glucose tolerance 3H panel"
      }
    ]
  }
}